For life-threatening or fatal SUSAR, by when must regulatory authorities be informed?

Enhance your knowledge of clinical trials with the ACRP GCP and Clinical Trial Principles Test. Study using diverse question types, hints, and immediate explanations. Equip yourself with essential tools for success!

Multiple Choice

For life-threatening or fatal SUSAR, by when must regulatory authorities be informed?

Explanation:
The timing point is how quickly serious safety signals must reach regulators. For life-threatening or fatal SUSARs, regulators require an expedited notification within seven days of when someone involved in the trial becomes aware of the event. This keeps safety authorities informed promptly so they can assess risk and take action if needed, while still allowing time to gather accurate details. Reporting as soon as possible is encouraged, but the explicit limit is seven days, with follow-up information provided as it becomes available. The other options miss this balance: 24 hours or immediate reporting is often impractical and not the defined deadline, and 15 days is too long for these severe events.

The timing point is how quickly serious safety signals must reach regulators. For life-threatening or fatal SUSARs, regulators require an expedited notification within seven days of when someone involved in the trial becomes aware of the event. This keeps safety authorities informed promptly so they can assess risk and take action if needed, while still allowing time to gather accurate details. Reporting as soon as possible is encouraged, but the explicit limit is seven days, with follow-up information provided as it becomes available. The other options miss this balance: 24 hours or immediate reporting is often impractical and not the defined deadline, and 15 days is too long for these severe events.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy